Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery

被引:45
作者
Balt, JC [1 ]
Mathy, MJ [1 ]
Nap, A [1 ]
Pfaffendorf, M [1 ]
van Zwieten, PA [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands
关键词
rat mesenteric artery; losartan; irbesartan; telmisartan; sympathetic neurotransmission;
D O I
10.1097/00005344-200107000-00015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of the AT(1)-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II (Ang II)-induced facilitation of noradrenergic neurotransmission was investigated in the isolated rat mesenteric artery under isometric conditions, Electrical field stimulation (2, 4, and 8 Hz) caused a frequency-dependent increase of contractile force, At stimulation frequen cies of 2, 4, and 8 Hz, Ang II (10 nM) increased the stimulation-induced vasoconstrictor responses by a factor 4.8 +/- 0.9, 2.9 +/- 0.7, and 1.3 +/- 0.1, respectively (p < 0.05 compared with control for all frequencies). The en hancement could be concentration-dependently antagonized by losartan (1 nM-1 muM), irbesartan (0.1 nM- 0.1 muM), and telmisartan (0.01 nM-0.01 muM). At a stimulation frequency of 2 Hz, the relation between stimulation-induced vasoconstrictor responses tin presence of Ang II 10 nM) and the concentration of the AT(1)-antagonists used could be described by linear regression. The order of potency concerning sympathoinhibition was telmisartan > irbesartan > losartan (p < 0.05 between linear regression lines). Contractile responses to exogenous noradrenaline were unaltered in the presence of Ang II 10 nM, We conclude that the facilitating effect of Ang LI on noradrenergic neurotransmission is mediated by presynaptically located AT(1)-receptors. Conversely, this facilitating effect can be dose-dependently counteracted by blockade of these receptors. Sympathoinhibitory properties are likely to contribute to the therapeutic effect of AT(1)-blockers, in particular in conditions in which the sympathetic nervous system is activated, such as congestive heart failure and hypertension.
引用
收藏
页码:141 / 148
页数:8
相关论文
共 43 条